Anne-Marie Koop

2 49 wistar rats. Physiol Res 2006;55:513–526. 28. Apitz C, Honjo O, Humpl T, Li J, Assad RS, Cho MY, Hong J, Friedberg MK, Redington AN. Biventricular structural and functional responses to aortic constriction in a rabbit model of chronic right ventricular pressure overload. J Thorac Cardiovasc Surg The American Association for Thoracic Surgery; 2012;144:1494–1501. 29. Friehs I, Cowan DB, Choi Y-H, Black KM, Barnett R, Bhasin MK, Daly C, Dillon SJ, Libermann TA, McGowan FX, Nido PJ del, Levitsky S, McCully JD. Pressure-overload hypertrophy of the developing heart reveals activation of divergent gene and protein pathways in the left and right ventricular myocardium. AJP Hear Circ Physiol 2013;304:H697-708. 30. Wilkins BJ, Dai YS, Bueno OF, Parsons SA, Xu J, Plank DM, Jones F, Kimball TR, Molkentin JD. Calcineurin/NFAT Coupling Participates in Pathological, but not Physiological, Cardiac Hypertrophy. Circ Res 2004;94:110–118. 31. Piao L, Marsboom G, Archer SL. Mitochondrial metabolic adaptation in right ventricular hypertrophy and failure. J Mol Med S. L. Archer, Harold Hines Jr. Department of Medicine, University of Chicago, Chicago, IL 60637, United States; 2010;88:1011–1020. 32. Steinberg SF. Oxidative stress and sarcomeric proteins. Circ Res 2013;112:393–405. 33. Wang G, Hamid T, Keith RJ, Zhou G, Partridge CR, Xiang X, Kingery JR, Lewis RK, Li Q, Rokosh DG, Ford R, Spinale FG, Riggs DW, Srivastava S, Bhatnagar A, Bolli R, Prabhu SD. Cardioprotective and antiapoptotic effects of heme oxygenase-1 in the failing heart. Circulation 2010;121:1912–1925. 34. Bogaard HJ, Mizuno S, Hussaini A a. Al, Toldo S, Abbate A, Kraskauskas D, Kasper M, Natarajan R, Voelkel NF. Suppression of histone deacetylases worsens right ventricular dysfunction after pulmonary artery banding in rats. Am J Respir Crit Care Med 2011;183: 1402–1410. 35. Bogaard HJ, Abe K, Noordegmaf AV, Voelkel NF. The right ventricle under pressure. Chest N. F. Voelkel, Department oj PulmonaryMedicine and Critical Care, Virginia Commonwealth University, Sanger Hall, Richmond, VA 23284; 2009;135:794–804. 36. Gomez-Arroyo J, Mizuno S, Szczepanek K, Tassell B Van, Natarajan R, Remedios CG Dos, Drake JI, Farkas L, Kraskauskas D, Wijesinghe DS, Chalfant CE, Bigbee J, Abbate A, Lesnefsky EJ, Bogaard HJ, Voelkel NF. Metabolic gene remodeling and mitochondrial dysfunction in failing right ventricular hypertrophy secondary to pulmonary arterial hypertension. Circ Hear Fail 2013;6:136–144. 37. Fang Y-H, Piao L, Hong Z, Toth PT, Marsboom G, Bache-Wiig P, Rehman J, Archer SL. Therapeutic inhibition of fatty acid oxidation in right ventricular hypertrophy: Exploiting Randle’s cycle. J Mol Med S.L. Archer, Medicine/Cardiology, University of Chicago, Chicago, IL 60637, United States; 2012;90:31–43. 38. Faber MJ, Dalinghaus M, Lankhuizen IM, Bezstarosti K, Verhoeven AJM, Duncker DJ, Helbing WA, Lamers JMJ. Time dependent changes in cytoplasmic proteins of the right ventricle during prolonged pressure overload. J Mol Cell Cardiol M. Dalinghaus, Erasmus MC-Sophia, Department of Pediatrics, Division of Pediatric Cardiology, 3015 GJ Rotterdam, Netherlands; 2007;43:197–209. 39. Neubauer S. The Failing Heart — An Engine Out of Fuel. N Engl J Med 2007;356:1140–1151. 40. RocheSL,RedingtonAN.Rightventricle:Wrongtargets?Anotherblowforpharmacotherapy in congenital heart diseases. Circulation 2013;127:314–316.